drugset / Trial / NCT02108639

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

NCT02108639

Phase 1 Completed 41 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-label

Summary

Assess the effect of renal function on the blood levels of DCV, ASV, BMS-791325.

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Asunaprevir Small molecule Oral
Subject Beclabuvir Small molecule Oral
Subject Daclatasvir Small molecule Oral